The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisions
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
The cloud-based platform enables long-term brain monitoring towards personalized treatment
Three new molecular diagnostic test panels for influenza and other common respiratory illnesses can be run together or alone using one patient sample
Self-collection devices designed for ease of use and safety
Clearance marks major shift beyond chemotherapy
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
The approval enables the company to directly sell health insurance plans to individuals and families while integrating its managed healthcare delivery model into retail offerings
Tamir brings more than 20 years of experience in the medical technology sector
Subscribe To Our Newsletter & Stay Updated
